Michael Erman
- Indexed articles, last 90 days
- 1
- Latest publication
- Aug 19, 2026
- Outlet visibility, for Brisbane Times
- Top 100K sites
- Earliest in this view
- Aug 19, 2026
Latest articles
‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say (opens the original)
Read excerpt
New York: Moderna and Merck said a personalised mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment that sent Moderna’s shares surging more than 170 per cent. The companies tested the vaccine together with Merck’s immunotherapy drug Keytruda, a widely used melanoma treatment. Thousands of patients who have undergone surgery to remove high-risk melanoma tumours could benefit as soon as next year if reg
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 100K sites
For Brisbane Times, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.